Modular PMA Guidance Issued As Program’s Premarket Approval Yield Grows
This article was originally published in The Gray Sheet
Executive Summary
FDA's new guidance on modular premarket approval applications includes measures designed to ensure ample time for reviewers to evaluate the submissions
You may also be interested in...
Modular PMA Review Times Go Up; FDA Proposes Performance Goals
FDA would like to incorporate Medical Device User Fee & Modernization Act performance goals into revised guidance for the modular PMA program
Modular PMA Review Times Go Up; FDA Proposes Performance Goals
FDA would like to incorporate Medical Device User Fee & Modernization Act performance goals into revised guidance for the modular PMA program
CDRH Contracts Review Cost Auditor; Expedited, Modular PMAs On The Rise
FDA's device center is meeting review targets for expedited premarket applications, with just over a quarter of the fiscal 2004 cohort completed